Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


CAPILLARY LEAK SYNDROME side effect

What is CAPILLARY LEAK SYNDROME ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   CAPILLARY LEAK SYNDROME and Recently Reported Side Effects   CAPILLARY LEAK SYNDROME and 15 most Active Side Effect polls   CAPILLARY LEAK SYNDROME and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with CAPILLARY LEAK SYNDROME

ANTINEOPLASTIC  AVASTIN  BEVACIZUMAB  BUSULFAN  BUSULFEX  CAMPATH  CETUXIMAB  CLOFAR  CLOFARABINE  CLOLAR  DENILEUKIN  DOCETAXEL  ENBREL  FEIBA  FLUDARA  GEMCITABINE  GEMTUZUMAB  GEMZAR  HERCEPTIN  INTERFERON  LYRICA  MABTHERA  METHOTREXATE  MITOXANGTRONE  NITRIC  NOXAFIL  ONTAK  ORTHOCLONE  PROGRAF  PROLEUKIN  PROSTIN  REVLIMID  RISPERDAL  SANDIMMUNE  TAXOL  TAXOTERE  TRASTUZUMAB  VELCADE  VESANOID  


Gemzar Side Effects Report #5648868-5
Physician from UNITED STATES reported GEMZAR problem on Feb 26, 2008. Female patient, 61 years of age, was diagnosed with ovarian cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, laboratory test abnormal, . GEMZAR dosage: 1500 MG, DAY1/DAY 8 SCHEDULE. During the same period patient was treated with CARBOPLATIN, ARANESP. Patient recovered.

Prostin Side Effects Report #5680970-4
PROSTIN E problem was reported by a Physician from SWITZERLAND on Mar 14, 2008. Female patient, child 9 years of age, was diagnosed with liver transplant and was treated with PROSTIN E. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, cardiovascular disorder, pyrexia, systemic inflammatory response syndrome, . PROSTIN E dosage: unknown. During the same period patient was treated with SIMULECT, PROGRAF, HEPARIN, ZINACEF, GARAMYCIN, AMPHO. Patient died on 08/09/2007.

Ontak Side Effects Report #5615033-7
Physician from UNITED STATES reported ONTAK problem on Jan 23, 2008. Female patient, 53 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, chest pain, hyperthyroidism, nausea, palpitations, vomiting, . ONTAK dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5615692-9
VELCADE problem was reported by a Physician from JAPAN on Jan 23, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, tumour lysis syndrome, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.


Campath Side Effects Report #5624153-2
Consumer or non-health professional from UNITED STATES reported CAMPATH problem on Feb 04, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia, infection prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, dyspnoea, fluid retention, . CAMPATH dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with TYLENOL, BENADRYL, BACTRIM, ANTIVIRALS NOS, RED BLOOD CELLS. Patient recovered.

Interferon Side Effects Report #5625459-3
INTERFERON GAMMA problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Female patient was diagnosed with lymphoma and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, renal failure, . INTERFERON GAMMA dosage: 0.025 MG/M2, QOD FOR 10 DOSES, SUBCUTANEOUS. During the same period patient was treated with PROLEUKIN, CYCLOPHOSPHAMIDE. Patient recovered.

Herceptin Side Effects Report #5626734-9
Consumer or non-health professional from GERMANY reported HERCEPTIN problem on Feb 13, 2008. Female patient, weighting 2.24 lb, was diagnosed with breast cancer metastatic and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, necrotising colitis, respiratory failure, . HERCEPTIN dosage: unknown. Patient died.

Gemzar Side Effects Report #5598562-4
GEMZAR problem was reported by a Physician from UNITED STATES on Jan 14, 2008. Female patient, 61 years of age, was diagnosed with ovarian cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, laboratory test abnormal, weight increased, . GEMZAR dosage: 1500 MG, DAY1/DAY 8 SCHEDULE. During the same period patient was treated with CARBOPLATIN, ARANESP. Patient recovered.

Herceptin Side Effects Report #5600782-7
Consumer or non-health professional from GERMANY reported HERCEPTIN problem on Jan 15, 2008. Female patient, weighting 2.24 lb, was diagnosed with breast cancer metastatic and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, necrotising colitis, respiratory failure, . HERCEPTIN dosage: unknown. Patient died.


Gemcitabine Side Effects Report #5607370-7
GEMCITABINE problem was reported by a Physician from FRANCE on Jan 18, 2008. Male patient, 68 years of age, was diagnosed with adenocarcinoma pancreas and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, malignant neoplasm progression, neutropenia, renal failure, . GEMCITABINE dosage: 1000 MG/M2, WEEKLY (1/W). Patient died.

Gemcitabine Side Effects Report #5607372-0
Physician from FRANCE reported GEMCITABINE problem on Jan 18, 2008. Female patient, 60 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, malignant neoplasm progression, renal failure, . GEMCITABINE dosage: 1000 MG/M2, WEEKLY (1/W). Patient was hospitalized. Patient died.

Risperdal Side Effects Report #5534654-3
RISPERDAL problem was reported by a Physician from NETHERLANDS on Nov 30, 2007. Female patient, weighting 123.5 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, face oedema, . RISPERDAL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, DEPAKENE. Patient recovered.

Taxotere Side Effects Report #5564597-0
Physician from BELGIUM reported TAXOTERE problem on Dec 10, 2007. Female patient, 55 years of age, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, cardiac failure, cardiomegaly, cholestasis, dermatitis allergic, dyspnoea, gilbert's syndrome, nail disorder, pleural effusion, . TAXOTERE dosage: unknown. During the same period patient was treated with MEDROL, FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Vesanoid Side Effects Report #5577966-X
VESANOID problem was reported by a Physician from AUSTRIA on Dec 21, 2007. Female patient, 23 years of age, was diagnosed with acute myeloid leukaemia and was treated with VESANOID. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . VESANOID dosage: unknown. Patient recovered.


Mabthera Side Effects Report #5512662-6
Physician from UNITED KINGDOM reported MABTHERA problem on Oct 31, 2007. Male patient, 74 years of age, was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, CORTICOSTEROID, ATARAX, POLARAMINE. Patient was hospitalized. Patient recovered.

Ontak Side Effects Report #5530610-X
ONTAK problem was reported by a Pharmacist from UNITED STATES on Nov 28, 2007. Male patient, 54 years of age, weighting 213.8 lb, was diagnosed with t-cell lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, dizziness, metabolic acidosis, multi-organ failure, respiratory failure, shock, syncope, systemic inflammatory response syndrome, . ONTAK dosage: unknown. Patient died on 04/23/2007.

Feiba Side Effects Report #5443324-1
Consumer or non-health professional from GERMANY reported FEIBA NF problem on Aug 29, 2007. Male patient, 36 years of age, weighting 176.4 lb, was diagnosed with haemophilia b with anti factor ix, haemorrhage and was treated with FEIBA NF. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, chills, sepsis, . FEIBA NF dosage: unknown. During the same period patient was treated with FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF. Patient was hospitalized. Patient died on 04/01/2007.

Clolar Side Effects Report #5455778-5
CLOLAR problem was reported by a Pharmacist from UNITED STATES on Sept 13, 2007. Female patient, child 10 years of age, weighting 74.96 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, hepatic function abnormal, hypotension, renal impairment, tumour lysis syndrome, . CLOLAR dosage: 57MG/DAILY/IV. During the same period patient was treated with HYDROCORTISONE, ONDANSETRON, VORICONAZOLE, ALLOPURINOL, ACYCLOVIR, BACTRIM, CETIRIZINE, HYDRALAZINE. Patient was hospitalized. Patient recovered.

Feiba Side Effects Report #5403757-6
Consumer or non-health professional from UNITED STATES reported FEIBA VH IMMUNO problem on July 26, 2007. Male patient, 36 years of age, weighting 176.4 lb, was diagnosed with haemophilia b with anti factor ix, haemorrhage and was treated with FEIBA VH IMMUNO. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, chills, . FEIBA VH IMMUNO dosage: unknown. During the same period patient was treated with FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA NF. Patient was hospitalized. Patient recovered.


Feiba Side Effects Report #5427344-9
FEIBA NF problem was reported by a Consumer or non-health professional from GERMANY on Aug 16, 2007. Male patient, 36 years of age, weighting 176.4 lb, was diagnosed with haemophilia b with anti factor ix, haemorrhage and was treated with FEIBA NF. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, chills, sepsis, . FEIBA NF dosage: unknown. During the same period patient was treated with FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF, FEIBA NF. Patient was hospitalized. Patient died on 04/01/2007.

Clofarabine Side Effects Report #5759120-1
Physician from CANADA reported CLOFARABINE problem on May 28, 2008. Male patient, child 10 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, hypotension, pulmonary oedema, renal failure, . CLOFARABINE dosage: unknown. During the same period patient was treated with CYTARABINE. Patient died on 05/24/2008.

Avastin Side Effects Report #5766320-3
AVASTIN problem was reported by a Physician from UNITED KINGDOM on May 27, 2008. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . AVASTIN dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with KENZEN, TAXOL, GEMZAR, ZOPHREN, METHYLPREDNISOLONE, POLARAMINE, RANITIDINE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 12/04/2007.

Gemcitabine Side Effects Report #5771945-5
Pharmacist from UNITED STATES reported GEMCITABINE problem on June 12, 2008. Female patient, 64 years of age, weighting 218.3 lb, was diagnosed with pancreatic carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, renal failure acute, septic shock, . GEMCITABINE dosage: unknown. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5782069-5
CLOFARABINE problem was reported by a Physician from CANADA on June 10, 2008. Male patient, child 10 years of age, weighting 96.78 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, hypotension, multi-organ failure, pulmonary oedema, renal failure, . CLOFARABINE dosage: 70 MG, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, HYDROCORTISONE. Patient died on 05/24/2008.

Revlimid Side Effects Report #5729625-8
Pharmacist from UNITED STATES reported REVLIMID problem on Apr 21, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, platelet count decreased, pulmonary oedema, . REVLIMID dosage: 25 MG, ORAL; 20 MG, ORAL; 15 MG, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5732977-6
CAMPATH problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia, infection prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, dyspnoea, fluid retention, . CAMPATH dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with TYLENOL, BENADRYL, BACTRIM, ANTIVIRALS NOS, RED BLOOD CELLS. Patient recovered.

Velcade Side Effects Report #5740433-4
Physician from JAPAN reported VELCADE problem on May 01, 2008. Male patient, 69 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, cardiac failure congestive, delirium, depressed level of consciousness, diastolic dysfunction, interstitial lung disease, nervous system disorder, pleural effusion, pulmonary oedema, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, AMLODIPINE BESYLATE, GLIMICRON, URSO, LANSOPRAZOLE, PURSENNID, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5747877-5
TAXOL problem was reported by a Health Professional from FRANCE on May 21, 2008. Female patient, 50 years of age, was diagnosed with ovarian epithelial cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . TAXOL dosage: unknown. During the same period patient was treated with GEMZAR, AVASTIN, KENZEN, PANTOPRAZOLE, PROZAC, LEXOMIL, CORTANCYL, WELLVONE. Patient was hospitalized. Patient died on 12/04/2007.

Velcade Side Effects Report #5753993-4
Physician from JAPAN reported VELCADE problem on May 16, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, tumour lysis syndrome, . VELCADE dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAXOBERON, SENNOSIDE A, SORBITOL, LECICARBON, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5703050-8
VELCADE problem was reported by a Physician from JAPAN on Mar 26, 2008. Male patient, 48 years of age, weighting 185.2 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, dyspnoea exertional, lymphocyte count decreased, neuropathy peripheral, pleural effusion, . VELCADE dosage: 2.60 MG, INTRAVENOUS, 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROXATIDINE ACETATE, ALLOPURINOL, DIFLUCAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, URSO. Patient recovered.

Fludara Side Effects Report #5703973-X
Physician from ITALY reported FLUDARA problem on Apr 08, 2008. Male patient, child 12 years of age, was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . FLUDARA dosage: UNIT DOSE: 50 MG. During the same period patient was treated with THYMOGLOBULINE, TREOSULFANECTION, FLUCONAZOLE, VALPROATE, ACYCLOVIR, FUROSEMIDE, CYCLOSPORINE, AMIKACIN SULPHATE. Patient died on 12/01/2007.

Taxotere Side Effects Report #5705988-4
TAXOTERE problem was reported by a Health Professional from UNITED STATES on Apr 07, 2008. Female patient, 59 years of age, weighting 278.0 lb, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, supraventricular tachycardia, . TAXOTERE dosage: unknown. During the same period patient was treated with PROCRIT, PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, HYDROCHLOROTHIAZIDE, CLARITIN, VOLTAREN, TAGAMET. Patient was hospitalized. Patient recovered.

Prostin Side Effects Report #5706109-4
Physician from SWITZERLAND reported PROSTIN VR SOLUTION problem on Apr 04, 2008. Female patient, child 9 years of age, was diagnosed with liver transplant and was treated with PROSTIN VR SOLUTION. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, cardiovascular disorder, pyrexia, systemic inflammatory response syndrome, . PROSTIN VR SOLUTION dosage: unknown. During the same period patient was treated with SIMULECT, PROGRAF, HEPARIN, ZINACEF, GARAMYCIN, AMPHO. Patient died on 08/09/2007.

Trastuzumab Side Effects Report #5715658-4
TRASTUZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2008. Female patient, weighting 161.2 lb, was diagnosed with breast cancer and was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, cardiac disorder, cardiac failure congestive, catheter related infection, hyperlipidaemia, inflammation, lung infiltration, lymphadenopathy, . TRASTUZUMAB dosage: 146MG WEEKLY X 52 IV. During the same period patient was treated with PACLITAXEL, ALPHAGAN, CALCIUM CARBONATE, COMPAZINE, COSOPT, DEXAMETHASONE, LISINOPRIL. Patient was hospitalized. Patient recovered.

Fludara Side Effects Report #5717481-3
Physician from ITALY reported FLUDARA problem on Apr 17, 2008. Male patient, child 12 years of age, was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . FLUDARA dosage: UNIT DOSE: 50 MG. During the same period patient was treated with THYMOGLOBULIN, TREOSULFANECTION, FLUCONAZOLE, VALPROATE, ACYCLOVIR, FUROSEMIDE, CYCLOSPORINE, AMIKACIN SULPHATE. Patient died on 12/01/2007.

Ontak Side Effects Report #5723490-0
ONTAK problem was reported by a Physician from UNITED STATES on June 11, 2007. Male patient was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . ONTAK dosage: unknown. Patient died.

Ontak Side Effects Report #5723498-5
Physician from UNITED STATES reported ONTAK problem on Jan 23, 2008. Female patient, 53 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, hyperthyroidism, . ONTAK dosage: unknown. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5723794-1
CLOFARABINE problem was reported by a Pharmacist from UNITED STATES on Apr 29, 2008. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, cytokine storm, multi-organ failure, pericardial effusion, . CLOFARABINE dosage: unknown. Patient recovered.

Avastin Side Effects Report #5342787-X
Physician from UNITED STATES reported AVASTIN problem on May 22, 2007. Female patient, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . AVASTIN dosage: 10 MG/KG, QOW. During the same period patient was treated with TAXOL, FILGRASTIM, ARANESP. Patient was hospitalized. Patient recovered.

Avastin Side Effects Report #5361280-1
AVASTIN problem was reported by a Physician from UNITED STATES on June 12, 2007. Male patient, weighting 182.0 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, . AVASTIN dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL. Patient recovered.

Gemzar Side Effects Report #5334822-X
Physician from UNITED STATES reported GEMZAR problem on May 21, 2007. Female patient, 74 years of age, was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, oedema peripheral, . GEMZAR dosage: unknown. During the same period patient was treated with TAXOL. Patient recovered.

Taxol Side Effects Report #5344206-6
TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, weighting 114.2 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, oedema peripheral, . TAXOL dosage: 258 MG. Patient recovered.

Lyrica Side Effects Report #5287130-X
Physician from NETHERLANDS reported LYRICA problem on Mar 27, 2007. Male patient, 54 years of age, weighting 180.8 lb, was diagnosed with neuralgia and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, venous thrombosis, . LYRICA dosage: unknown. Patient was hospitalized. Patient recovered.

Feiba Side Effects Report #5288517-1
FEIBA VH IMMUNO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2007. Male patient, 36 years of age, weighting 176.4 lb, was diagnosed with haemophilia b with anti factor ix, haemorrhage, bronchitis and was treated with FEIBA VH IMMUNO. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, chills, . FEIBA VH IMMUNO dosage: unknown. During the same period patient was treated with FEIBA VH IMMUNO, FEIBA VH IMMUNO, FEIBA VH IMMUNO, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Docetaxel Side Effects Report #5289670-6
Health Professional from CANADA reported DOCETAXEL problem on Mar 30, 2007. Female patient, 40 years of age, weighting 174.8 lb, was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, diarrhoea, disease progression, dyspnoea, pleural effusion, pneumonitis, respiratory failure, . DOCETAXEL dosage: unknown. During the same period patient was treated with SERAX, SYNTHROID, DILAUDID, MAGIC MOUTHWASH. Patient was hospitalized. Patient died on 09/01/2006.

Gemzar Side Effects Report #5267392-5
GEMZAR problem was reported by a Physician from UNITED STATES on Mar 09, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, lung infiltration, . GEMZAR dosage: 2090 MG, UNK. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5268191-0
Physician from FRANCE reported ENBREL problem on Mar 05, 2007. Male patient, 44 years of age, was diagnosed with ankylosing spondylitis, asthma, migraine and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, carbon monoxide diffusing capacity decreased, dyspnoea, lung disorder, obstructive airways disorder, oedema peripheral, vital capacity decreased, weight increased, . ENBREL dosage: unknown. During the same period patient was treated with DEPAKENE, VENTOLIN, OXYCONTIN, PERISTALTINE, TRANSIPEG, TAHOR, AVLOCARDYL, NEXIUM. Patient recovered.

Lyrica Side Effects Report #5269345-X
LYRICA problem was reported by a Physician from NETHERLANDS on Mar 07, 2007. Male patient, 54 years of age, was diagnosed with neuralgia and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, venous thrombosis, . LYRICA dosage: unknown. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5679844-4
Physician from SWITZERLAND reported PROGRAF problem on Mar 07, 2008. Female patient, child 8 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: ascites, capillary leak syndrome, cardiac arrest, cardiovascular disorder, haemodialysis, myocardial ischaemia, pericardial effusion, pleural effusion, . PROGRAF dosage: 2 MG, ORAL. During the same period patient was treated with SIMULECT, PROSTIN E, HEPARIN, ZINACEF, GARAMYCIN, AMPHO MORONAL, MORPHINE, GANCICLOVIR. Patient died on 08/09/2007.

Methotrexate Side Effects Report #5598651-4
METHOTREXATE problem was reported by a Physician from GERMANY on Jan 08, 2008. Male patient, child 12 years of age, was diagnosed with prophylaxis against graft versus host disease, stem cell transplant and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, capillary leak syndrome, dermatitis exfoliative, mucosal inflammation, multi-organ failure, renal failure, . METHOTREXATE dosage: 2.5 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, TREOSULPHAN, MELPHALAN, CYCLOSPORINE. Patient died.

Clofar Side Effects Report #5610693-9
Health Professional from UNITED STATES reported CLOFAR problem on Jan 30, 2008. Male patient, weighting 90.39 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFAR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, capillary leak syndrome, cardiac arrest, cardiac disorder, continuous haemodiafiltration, hypotension, oedema peripheral, oliguria, respiratory distress, . CLOFAR dosage: 50 MG QD -5 DAYS PLANNED IV DRIP. Patient died on 01/12/2008.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about CAPILLARY LEAK SYNDROME side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about CAPILLARY LEAK SYNDROME